"Patient Access Location; Research Institute; Alzheimer's Prevention Research"

During the past decade, Care Access Research - Warwick conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Care Access Research - Warwick" #1 sponsor was "Allergan" with 1 trials, followed by "Eli Lilly and Company" with 1 trials sponsored, "Gan and Lee Pharmaceuticals, USA" with 1 trials sponsored, "Mylan Inc." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Care Access Research - Warwick" #1 collaborator was "Mylan GmbH" with 1 trials as a collaborator and "Valneva Austria GmbH" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Care Access Research - Warwick" are "Diabetes Mellitus, Type 1" (2 trials), "Alzheimer Disease" (1 trials), "Diabetes Mellitus" (1 trials), "Gastroparesis" (1 trials) and "Lyme Disease" (1 trials). Many other conditions were trialed in "Care Access Research - Warwick" in a lesser frequency.

Most popular intervention types in "Care Access Research - Warwick" are "Drug" (5 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Cenicriviroc" (1 trials), "Donanemab" (1 trials), "FlexPen NovoLog®" (1 trials) and "Gan & Lee Insulin Lispro Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Care Access Research - Warwick" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Care Access Research - Warwick". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Care Access Research - Warwick, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Care Access Research - Warwick, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".